Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 115

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 15
Chunk 115
---
 dated April 10, 2013.
     
    10-Q
     
    001-14895
     
    10.1
     
    5/9/13

     10.10*
     
    First Amendment to License Agreement by and among The University of Western Australia, Sarepta Therapeutics, Inc., and Sarepta International CV dated June 19, 2016.
     
    10-Q
     
    001-14895
     
    10.1
     
    8/9/16

     10.11†
     
    Amendment No. 1 to the Sarepta Therapeutics, Inc. Amended and Restated 2011 Equity Incentive Plan
     
    8-K
     
    001-14895
     
    10.1
     
    6/30/15

     10.12
     
    Asset Purchase Agreement dated February 20, 2017 by and between Sarepta Therapeutics Inc. and Gilead Sciences, Inc.
     
    10-Q
     
    001-14895
     
    10.1
     
    5/4/17

     10.13†
     
    Employment Agreement, dated as of June 26, 2017, between Sarepta Therapeutics, Inc. and Douglas S. Ingram
     
    8-K
     
    001-14895
     
    10.1
     
    6/28/17

     10.14†
     
    Change in Control and Severance Agreement by and between Douglas S. Ingram and Sarepta Therapeutics, Inc., effective June 26, 2017
     
    8-K
     
    001-14895
     
    10.2
     
    6/28/17

     10.15†
     
    Amendment No. 1 to the Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan
     
    8-K
     
    001-14895
     
    10.3
     
    6/28/17

     10.16†
     
    Restricted Stock Agreement under the 2014 Employment Commencement Incent